PH31266A - Methods of inhibiting weight gain or inducing weight loss. - Google Patents

Methods of inhibiting weight gain or inducing weight loss.

Info

Publication number
PH31266A
PH31266A PH49576A PH49576A PH31266A PH 31266 A PH31266 A PH 31266A PH 49576 A PH49576 A PH 49576A PH 49576 A PH49576 A PH 49576A PH 31266 A PH31266 A PH 31266A
Authority
PH
Philippines
Prior art keywords
methods
inhibiting
inducing
weight loss
weight
Prior art date
Application number
PH49576A
Other languages
English (en)
Inventor
Henry U Bryant
Jeffrey A Dodge
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH31266A publication Critical patent/PH31266A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PH49576A 1993-12-21 1994-12-19 Methods of inhibiting weight gain or inducing weight loss. PH31266A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/171,291 US5578613A (en) 1993-12-21 1993-12-21 Methods for inhibiting weight gain or inducing weight loss

Publications (1)

Publication Number Publication Date
PH31266A true PH31266A (en) 1998-06-18

Family

ID=22623225

Family Applications (1)

Application Number Title Priority Date Filing Date
PH49576A PH31266A (en) 1993-12-21 1994-12-19 Methods of inhibiting weight gain or inducing weight loss.

Country Status (16)

Country Link
US (2) US5578613A (fr)
EP (1) EP0659423A1 (fr)
JP (1) JPH07196492A (fr)
KR (1) KR950016741A (fr)
CN (1) CN1107707A (fr)
AU (1) AU8154094A (fr)
CA (1) CA2138455A1 (fr)
CZ (1) CZ322294A3 (fr)
HU (1) HUT71342A (fr)
IL (1) IL112044A (fr)
NO (1) NO944923L (fr)
NZ (1) NZ270182A (fr)
PH (1) PH31266A (fr)
RU (1) RU94044357A (fr)
TW (1) TW272126B (fr)
ZA (1) ZA9410090B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417198B1 (en) 1993-12-21 2002-07-09 Eli Lilly And Company Methods of inhibiting CNS problems in post-menopausal women
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
US5900418A (en) * 1997-02-10 1999-05-04 Synapse Pharmaceuticals International, Inc. Method for treatment of obesity
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.
US6054446A (en) 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
WO1999065489A1 (fr) 1998-06-16 1999-12-23 Eli Lilly And Company Procedes relatifs a l'augmentation des niveaux d'acetylcholine
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
HUP0200871A3 (en) 1999-05-04 2004-04-28 Strakan Int Ltd Androgen glycosides and androgenic activity thereof
WO2006031963A2 (fr) * 2004-09-13 2006-03-23 Lipomics Technologies, Inc. Marqueurs metabolites destines a la gestion ponderale
WO2006050999A2 (fr) * 2004-11-15 2006-05-18 Obe Therapy Biotechnology S.A.S Compositions pharmaceutiques et procedes de reduction de la graisse corporelle
CA2707549A1 (fr) 2007-12-03 2009-06-11 Itzik Harosh Inhibiteurs boropeptidiques de l'enterokinase et leurs utilisations dans le traitement de l'obesite, de la surcharge ponderale et/ou des maladies associees avec un metabolisme anormal des lipides
US20140378424A1 (en) * 2011-12-30 2014-12-25 Rosscreening, Inc. Estrogen receptor modulators for reducing body weight

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW303299B (fr) * 1993-07-22 1997-04-21 Lilly Co Eli

Also Published As

Publication number Publication date
RU94044357A (ru) 1996-10-20
IL112044A0 (en) 1995-03-15
NZ270182A (en) 1996-08-27
TW272126B (fr) 1996-03-11
IL112044A (en) 1999-01-26
JPH07196492A (ja) 1995-08-01
HU9403673D0 (en) 1995-02-28
KR950016741A (ko) 1995-07-20
AU8154094A (en) 1995-06-29
EP0659423A1 (fr) 1995-06-28
CA2138455A1 (fr) 1995-06-22
US5578614A (en) 1996-11-26
NO944923L (no) 1995-06-22
US5578613A (en) 1996-11-26
ZA9410090B (en) 1996-06-19
NO944923D0 (no) 1994-12-19
CZ322294A3 (en) 1995-09-13
HUT71342A (en) 1995-11-28
CN1107707A (zh) 1995-09-06

Similar Documents

Publication Publication Date Title
EP0612249A4 (en) Methods of inhibiting restenosis.
PH30895A (en) Detoxification of soil.
EP0604748A3 (fr) Manchon de trocart.
EP0621686A3 (fr) Amplificateur.
EP0601322A3 (fr) Inhibiteur de déaminase d'adénosine.
ZA956991B (en) Methods of inhibiting ulcerative mucositis.
EP0614944A3 (fr) Composition intumescente du type deux-composantes.
PH31266A (en) Methods of inhibiting weight gain or inducing weight loss.
AU7680891A (en) The method of inhibiting discoloration of produce
IL107830A0 (en) Missile
EP0605164A3 (fr) Trieuse-vérificatrice pondérale.
PH31326A (en) Methods of inhibiting breast disorders.
ZA927463B (en) Transplant protective coating.
GR3026571T3 (en) Preparation of 2-H-heptafluoropropane.
ZA943316B (en) Process for the preparation of microballs and microballs thus obtained.
GB9424674D0 (en) Polypeptudes which inhibit NADPH oxidase complex
EP0652284A3 (fr) Préparation de la bière.
EP0565484A3 (en) Hiv-protease inhibiting morpholin- and thiomorpholin-4-ylamides
ZA949404B (en) Methods of inhibiting the effects of amyloidogenic proteins
EP0618222A3 (en) Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
PL297110A1 (en) Herbicidal sulphonamides, method of obtaining novel sulphonamides and herbicide as such
AU4519293A (en) Soft steel projectile
EP0624089A4 (en) Methods.
EP0607543A3 (fr) Ski.
GB9316706D0 (en) Divers weight